A versatile cell line for establishing potency of cell type-specific AAV transgenes
Potency assays are essential for adeno-associated virus (AAV) therapy development, allowing simple and quantitative assessments of therapeutic activity, target engagement, vector stability, and activity per batch. However, cell culture-based AAV potency assays are generally hampered by two limitatio...
Saved in:
Main Authors: | Refugio A. Martinez, Yemeserach M. Bishaw, Meagan A. Quinlan, Erin L. Groce, Bryan B. Gore, Ed S. Lein, John K. Mich, Boaz P. Levi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050124002171 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of cell lines with increased susceptibility to diverse adeno-associated viral vectors to enable in vitro potency assays
by: James Zengel, et al.
Published: (2025-03-01) -
CRISPR screen reveals modifiers of rAAV production including known rAAV infection genes playing an unexpected role in vector production
by: Emily E. O’Driscoll, et al.
Published: (2025-03-01) -
Enhanced membrane protein production in HEK293T cells via ATF4 gene knockout: A CRISPR-Cas9 mediated approach
by: Byung-Jo Choi, et al.
Published: (2025-01-01) -
Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primates
by: Mengping Liu, et al.
Published: (2025-03-01) -
Secreted PD-L1 alleviates inflammatory arthritis in mice through local and systemic AAV gene therapy
by: Wenjun Li, et al.
Published: (2025-02-01)